会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • GLP-1 DERIVATIVES
    • GLP-1衍生物
    • WO2013037690A1
    • 2013-03-21
    • PCT/EP2012/067364
    • 2012-09-06
    • NOVO NORDISK A/SLAU, JesperBLOCH, PawKOFOED, JacobGARIBAY, Patrick
    • LAU, JesperBLOCH, PawKOFOED, JacobGARIBAY, Patrick
    • C07K14/605A61K38/26
    • C07K14/605A61K38/00A61K38/26
    • The invention relates to a derivative of a GLP-1 peptide, which peptide has two Lys residues, namely a first and a second Lys residue, and a maximum of eight amino acid changes as compared to GLP-1(7-37) (SEQ ID NO: 3), which derivative comprises two protracting moieties attached to the epsilon amino group of said first and second Lys residue, respectively, via a linker, wherein the protracting moiety is selected from Chem. 15: HOOC-(CH 2 ) x -CO-*, and Chem. 16: HOOC-C 6 H 4 -O-(CH 2 ) y -CO-*, in which x is an integer in the range of 10-16, and y is an integer in the range of 8-12; and the linker comprises a first linker element *-NH-CH(CH 2 OH)-CO-*. A preferred linker is g Glu-Ser-Ser-Gly-Ser-Ser-Gly (SEQ ID NO: 2). The derivative of the invention has a very good potency, and a very good binding to the GLP-1 receptor. The invention also relates to the pharmaceutical use of the derivative, for example in the treatment and/or prevention of all forms of diabetes and related diseases.
    • 本发明涉及GLP-1肽的衍生物,该肽与GLP-1(7-37)(SEQ)相比具有两个Lys残基,即第一和第二Lys残基,最多八个氨基酸变化 SEQ ID NO:3),该衍生物分别包含通过接头分别连接到所述第一和第二Lys残基的ε氨基的两个伸长部分,其中伸长部分选自Chem。 15:HOOC-(CH 2)x -CO- *,和Chem。 16:HOOC-C 6 H 4 -O-(CH 2)y -CO- *,其中x是10-16的整数,y是8-12的整数; 并且连接体包含第一连接体元件* -NH-CH(CH 2 OH)-CO- *。 优选的接头是g Glu-Ser-Ser-Gly-Ser-Ser-Gly(SEQ ID NO:2)。 本发明的衍生物具有非常好的效力,并且与GLP-1受体具有非常好的结合。 本发明还涉及衍生物的药物用途,例如用于治疗和/或预防所有形式的糖尿病和相关疾病。